Join our renowned experts as they discuss and share their experience in autosomal dominant polycystic kidney disease (ADPKD) management in this learning series.

Objectives

• Discover the most common manifestations of ADPKD and the role of genetic testing
• Reflect on the past, present, and future of ADPKD management
• Identify patients with ADPKD for whom tolvaptan may be appropriate
• Recognize the role of V2 receptor signalling pathways